COVID ‘Compromise’ on International IP Underscores Need for New Approach
For COVID treatments and diagnostics to be broadly available at affordable prices, their IP must be considered a global public good.
TRIPS
-
Read more: COVID ‘Compromise’ on International IP Underscores Need for New Approach -
Read more: Addressing IP Barriers in the Context of a Pandemic Treaty Addressing IP Barriers in the Context of a Pandemic Treaty
Tackling the question of how to address the needs for sharing scientific research is fundamental to any pandemic treaty discussion.
-
Read more: FRAND Terms for Pandemic-essential Intellectual Property Rights FRAND Terms for Pandemic-essential Intellectual Property Rights
The use of fair, reasonable and non-discriminatory (“FRAND”) terms in the licensing of intellectual property rights could foster cooperation in pandemics.
-
Read more: Decolonizing the Pandemic Treaty Through Vaccine Equity Decolonizing the Pandemic Treaty Through Vaccine Equity
Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.
-
Read more: The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good
The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.
-
Read more: Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic
Activists in the access-to-medicines movement have mobilized to combat the threat of vaccine/therapeutic apartheid during the COVID-19 pandemic.
-
Read more: The Prospects for an IP Waiver Under the TRIPS Agreement The Prospects for an IP Waiver Under the TRIPS Agreement
Going forward, practical solutions should focus on scaling up manufacturing and supply, and improving access and affordability.
-
Read more: US Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean? US Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean?
An explanation of the WTO waiver of COVID-19 intellectual property, what the U.S. declaration of support means, and likely effects of the waiver.
-
Read more: Webinar, 6/28: Procedural Aspects of Compulsory Licensing under TRIPS Webinar, 6/28: Procedural Aspects of Compulsory Licensing under TRIPS
Join us at yet another webinar with J. Wested at the University of Copenhagen. This time we will debate procedural issues in compulsory licensing with H. Grosse Ruse-Kahn (University of Cambridge) & M. Desai (Eli Lilly). Further information on our webinar series is available at here, here, and below: Procedural Aspects of Compulsory Licensing under Trade-Related Aspects of Intellectual…